The symposium aims to raise awareness of the latest treatment advances in bladder, renal and prostate cancer, to share learnings from the management of these new drugs and to collectively discuss some of the unanswered immuno-oncology questions.
Dr Peter Black
Senior Research Scientist, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia
Dr Black is a surgeon scientist with clinical sub-specialty interest in the treatment of urologic cancers, especially bladder and prostate cancer. Dr Black trained with one of the premier bladder cancer research groups in the world at M.D. Anderson Cancer Center in Houston, Texas, and has now established a research group at the Vancouver Prostate Centre.
Some of his research interests include novel targeted therapies for bladder cancer. Dr Black is an active clinical trialist in this field and is study chair of the SWOG S1605 trial testing an immune checkpoint inhibitor in BCG-unresponsive high-risk non-muscle invasive bladder cancer.
He has authored >240 peer-reviewed publications and his scientific work has been published in >350 abstracts at national and international meetings. He is a consultant/adviser to GenomeDx Biosciences, Janssen, Astellas, Amgen, Sitka, AbbVie, Bristol Myers Squibb, Bayer, Biosyent, Sanofi, Urogen, and Roche/Genentech.
Associate Professor Paul Neeson, Cancer Immunology Group Leader, Peter MacCallum Cancer Centre
Associate Professor Andrew Weickhardt, Senior Clinical Research Fellow, Olivia Newton-John Cancer Research Institute and Medical Oncologist, Austin Health
Associate Professor Renea Taylor, Senior Lecturer and Research Fellow, Department of Physiology and Biomedicine Discovery Institute, Monash University
Associate Professor Shahneen Sandhu, Consultant Medical Oncologist and Researcher, Peter MacCallum Cancer Centre
Associate Professor Shankar Siva, Radiation Oncologist and NHMRC Fellow, Peter MacCallum Cancer Centre
Dr Paul Anderson, Consultant Urologist, Royal Melbourne Hospital
Associate Professor Joseph Ischia, Urologist, Austin Health and University of Melbourne
Dr Shirley Wong, Consultant Medical Oncologist, Western Health
There will be an opportunity to share your thoughts during interactive case-based and panel discussions.
Friday 28 February 2020, 8.00am - 12.30pm
VCCC Building, Level 7 Lecture Theatre
Registration is FREE and includes refreshments and a light lunch.
Please contact Lauren King, Program Manager, VCCC Research and Education Lead Program, if you have any questions.